In gastric cancer, the expression of PD-L1 has been associated with T-cell exhaustion and impaired anti-tumor immunity Preclinical studies have shown that targeting this axis with anti-PD-1 antibodies can reinvigorate T-cell responses, leading to enhanced tumor control. Here, CD274 is linked to gastric cancer.